Results 91 to 100 of about 70,538 (300)

Genetic analysis of self-associating immunoglobulin G rheumatoid factors from two rheumatoid synovia implicates an antigen-driven response. [PDF]

, 1992
Although much has been learned about the molecular basis of immunoglobulin M (IgM) rheumatoid factors (RFs) in healthy individuals and in patients with mixed cryoglobulinemia and rheumatoid arthritis, little is known about the genetic origins of the ...
Carson, DA, Chen, PP, Deftos, M, Huang, DF, Kozin, F, Lu, EW, Olee, T, Soto-Gil, RW   +7 more
core  

Subcutaneous Immunoglobulin-G Replacement Therapy with Preparations Currently Available in the United States for Intravenous or Intramuscular Use: Reasons and Regimens [PDF]

, 2005
For patients who require replacement therapy for primary immunodeficiency, subcutaneous infusions of immunoglobulin G (IgG) may be preferable to intravenous infusions for several reasons.
Akhilesh Chouksey, Kimberly Duff, Nancy Wasserbauer, Melvin Berger   +3 more
core   +2 more sources

Transient constrictive pericarditis in Bruton disease: a case report

Российский кардиологический журнал
Introduction. Constrictive pericarditis is a long-term consequence of any pathological process developing in the pericardium due to fibrinous thickening and calcification of its layers, which prevents normal cardiac diastolic filling. One of its forms is
S. V. Kruchinova, K. V. Skaletsky, E. K. Donets, A. M. Namitokov, M. V. Karibova, E. D. Kosmacheva   +5 more
doaj   +1 more source

Does intravenous immunoglobulin therapy prolong immunodeficiency in transient hypogammaglobulinemia of infancy?

Pediatric Reports, 2013
Transient hypogammaglobulinemia of infancy (THI) is characterized by recurrent infections and one or more reduced serum immunoglobulin levels. Typically, THI patients recover spontaneously, mostly within 30-40 months of age, but sometimes recovery may be
Lale Memmedova, Elif Azarsiz, Neslihan Edeer Karaca, Guzide Aksu, Necil Kutukculer   +4 more
doaj   +1 more source

Efficacy and safety of human intravenous immunoglobulin 5% (Ig VENA) in pediatric patients affected by primary immunodeficiency

International Journal of Immunopathology and Pharmacology, 2020
Patients affected by primary immunodeficiencies are characterized for high susceptibility for severe infections. Our data demonstrate Kedrion 5% intravenous immunoglobulin G (IVIg) treatment effective and safe as replacement therapy for children and ...
Silvia Ricci, Francesca Lippi, Clementina Canessa, Chiara Guarnieri, Roberta Macchia, Chiara Azzari   +5 more
doaj   +1 more source

Simvastatin Restores Uteroplacental Hemodynamics and Trophoblast Function in Obstetric Antiphospholipid Syndrome in a Placenta‐on‐a‐Chip Model

Advanced Healthcare Materials, EarlyView.
Simvastatin mitigates placental hypoperfusion in OAPS by ameliorating abnormal uteromaternal hemodynamics and enhancing trophoblast invasion via optimized endothelial cell interactions under pathological shear stress, as evidenced by results from a placenta‐on‐a‐chip platform.
Hongli Liu, Yuan Wang, Yanjun Cai, Ruixin Guo, Shunhua Liu, Tingting Chen, Tingting Sun, Ruiheng Huo, Tengwei Liu, Qingfeng Lv, Xietong Wang   +10 more
wiley   +1 more source

Membranoproliferative Glomerulonephritis and X-Linked Agammaglobulinemia: An Uncommon Association

Case Reports in Pediatrics, 2014
Introduction. X-linked agammaglobulinemia (XLA) is a primary immunodeficiency characterized by agammaglobulinemia requiring replacement treatment with immunoglobulin.
Vasco Lavrador, Filipa Correia, Rita Sampaio, Cristina Cândido, Maria Sameiro-Faria, Laura Marques, Conceição Mota   +6 more
doaj   +1 more source

Bifunctional Surfaces With Immobilized Antibodies and Bioactive Peptides Mediate Selective Capture and Proliferation of Endothelial Colony‐Forming Cells

Advanced Healthcare Materials, EarlyView.
A tunable bifunctional surface is developed by combining Fc‐binding peptides and RGD motifs to present oriented antibodies alongside integrin‐mediated signaling. The platform selectively captures endothelial colony‐forming cells while promoting their adhesion and proliferation.
Hugo A. Level, Marc‐Antoine Campeau, Mohamed A. Elkhodiry, Gaétan Laroche, Jean‐François Tanguay, Corinne A. Hoesli   +5 more
wiley   +1 more source

Variation in immunoglobulin use and impact on survival in myeloma

eJHaem
Serious infection is common in patients with multiple myeloma due to immune deficiency from the underlying disease and/or its treatment. Immunoglobulin replacement is one approach to reduce infection risk in these patients.
Khai Li Chai, Cameron Wellard, LTP Thao, Naomi Aoki, Elizabeth M Moore, Bradley M Augustson, Akshay Bapat, Hilary Blacklock, Wee J Chng, Rachel Cooke, Cecily J Forsyth, Yeow‐Tee Goh, Nada Hamad, Simon J Harrison, P Joy Ho, Jay Hocking, Ian Kerridge, Jin Seok Kim, Kihyun Kim, Tracy King, Georgia J McCaughan, Peter Mollee, C Orla Morrissey, Nick Murphy, Hang Quach, Xuan Ni Tan, Allison CY Tso, Kimberly SQ Wong, Sung‐Soo Yoon, Andrew Spencer, Erica M Wood, Zoe K McQuilten   +31 more
doaj   +1 more source

Endogenous immunoglobulins and sepsis: New perspectives for guiding replacement therapies

International Journal of Antimicrobial Agents, 2015
The recently emerging concept of immunosuppression developing in the field of severe sepsis generated the need to measure circulating immunoglobulins as part of the necessary tests to evaluate immunocompetence status in patients suffering from this condition. Serum concentrations can be used as a surrogate marker of the final outcome and as a biomarker
Bermejo-Martin, J.F., Giamarellos-Bourboulis, E.J.   +1 more
openaire   +3 more sources